Triamterene And Hydrochlorothiazide
Product Images NDC 70934-159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 70934-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 159 30 Master Bottle Label Approval Rev B 02 19

70934 159 30 Master Bottle Label Approval   Rev B 02 19
NDC number 70934-150 is assigned to a combination medication containing the active ingredients Spironolactone and Hydrochlorothiazide. The medication is in tablet form and is used for treating high blood pressure (hypertension) and fluid retention (edema). The rest of the text is not available or readable.*
FDA Label Image

Triamterene Chemical Structure (Triamterene And Hctz Tabs 1)

FDA Label Image

Hydrochlorothiazide Chemical Structure (Triamterene And Hctz Tabs 2)

Hydrochlorothiazide Chemical Structure (Triamterene And Hctz Tabs 2)
Hydrochlorothiazide is a medication used to treat high blood pressure (hypertension) and fluid retention (edema). It works by increasing the amount of salt and water eliminated from the body through urination. This helps reduce blood pressure and swelling.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.